REG - Craneware plc - Total Voting Rights

CranewareAnnouncement

Yesterday 09:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251022:nRSV3951Ea&default-theme=true

RNS Number : 3951E  Craneware plc  22 October 2025

 

Craneware plc

 

("Craneware" or the "Company" or the "Group")

 

Total Voting Rights

 

 

22 October 2025 - Following recent share option exercise transactions by
employees, the Company has transferred Ordinary Shares previously held in
treasury to satisfy those share option exercise transactions.

 

As a result, the Company's issued share capital now consists of 35,542,169
Ordinary Shares, of which 110,302 remain held in treasury. Accordingly, the
total number of Ordinary Shares in the Company with voting rights is
35,431,867. This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

 

Craneware plc
                                             +44
(0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma Strategic
Communications
+44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Sarah Peters
                        craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker)
                     +44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint Broker)
                          +44 (0)20 7597 5970

Patrick Robb, Virginia Bull, James Smith

Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Patrick Dologhan

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus(®) cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRPKBBBFBDKNKB



            Copyright 2019 Regulatory News Service, all rights reserved